CONNECT WITH US
HealthTech

HealthTech

Study may explain why IBD patients react to foods they once tolerated

Medical Xpress logo

Published on

Add as a preferred source on Google
Study may explain why IBD patients react to foods they once tolerated

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A new study, to be published in Gastroenterology, finds that gut inflammation can change the way gut bacteria break down food—possibly triggering immune reactions to foods that were previously fine to eat. The findings may help explain why so many people with inflammatory bowel disease (IBD) react badly to foods like dairy or gluten, even in remission.

IBD, which includes Crohn's disease and ulcerative colitis, is marked by flare-ups of severe inflammation, and many patients change their diets to manage symptoms, despite limited evidence that this helps. About two-thirds of IBD patients report food-related symptoms. Dairy, wheat and fiber are the most frequently blamed triggers, but why they cause problems has remained unclear.

The gut microbiota, the trillions of bacteria living in the intestines, may hold the answer. These bacteria help digest foods that human enzymes can't process alone, and prior research has shown IBD patients often have altered gut bacteria. This study identifies a novel mechanism by which that alteration drives food reactions.

"The microbiome acts as a metabolic organ, helping us digest food components, including those that can trigger gut reactions," said study author Alberto Caminero, Ph.D. "Our study shows that inflammation impairs this microbial digestive capacity, potentially contributing to adverse food reactions and opening new possibilities for microbiome-based therapies to restore this function in IBD patients."

D.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.